eHealth Tools to Provide Structured Assistance for Atrial Fibrillation Screening, Management, and Guideline‐Recommended Therapy in Metropolitan General Practice: The AF‐SMART Study

Background This eH ealth implementation study aimed to evaluate strategies to promote opportunistic atrial fibrillation ( AF ) screening using electronic screening prompts and improve treatment using electronic decision support ( EDS ) software. Methods and Results An electronic screening prompt app...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Heart Association Vol. 8; no. 1; p. e010959
Main Authors Orchard, Jessica, Neubeck, Lis, Freedman, Ben, Li, Jialin, Webster, Ruth, Zwar, Nicholas, Gallagher, Robyn, Ferguson, Caleb, Lowres, Nicole
Format Journal Article
LanguageEnglish
Published England John Wiley and Sons Inc 08.01.2019
Wiley
Subjects
Online AccessGet full text
ISSN2047-9980
2047-9980
DOI10.1161/JAHA.118.010959

Cover

More Information
Summary:Background This eH ealth implementation study aimed to evaluate strategies to promote opportunistic atrial fibrillation ( AF ) screening using electronic screening prompts and improve treatment using electronic decision support ( EDS ) software. Methods and Results An electronic screening prompt appeared whenever an eligible patient's (aged ≥65 years, no AF diagnosis) medical record was opened in participating general practices. General practitioners and practice nurses offered screening using a smartphone ECG, with validated AF algorithm. Guideline-based EDS was provided to assist treatment decisions. Deidentified data were collected from practices using a data extraction tool. General practices (n=8) across Sydney, Australia, screened for a median of 6 months. A total of 1805 of 11 476 (16%) eligible patients who attended were screened (44% men, mean age 75.7 years). Screening identified 19 (1.1%) new cases of AF (mean age, 79 years; mean CHA DS - VAS c, 3.7; 53% men). General practitioners (n=30) performed 70% of all screenings (range 1-448 patients per general practitioner). The proportion of patients with AF who had CHA DS - VAS c ≥2 for men or ≥3 for women prescribed oral anticoagulants was higher for those diagnosed during the study: 15 of 18 (83%) for screen-detected and 39 of 46 (85%) for clinically detected, compared with 933 of 1306 (71%) patients diagnosed before the study ( P<0.001). The EDS was accessed 111 times for patients with AF and for 4 of 19 screen-detected patients. Conclusions The eH ealth tools showed promise. Adherence to guideline-based oral anticoagulant prescription was significantly higher in patients diagnosed during the study period, although the EDS was only used in a minority. While the proportion of eligible patients screened and EDS use was relatively low, further refinements may improve uptake in clinical practice. Clinical Trial Registration URL : www.anzctr.org.au . Unique identifier: ACTRN 12616000850471.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
This work was presented on the Digital Health Stage and as a poster at the European Society of Cardiology Congress, August 25–29, 2018, in Munich, Germany, and at the Cardiac Society of Australia and New Zealand Scientific Meeting, August 2–5, 2018, in Brisbane, Australia.
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.118.010959